4th Quarter - Report

COVINGTON & BURLING LLP for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

OTC drugs and cosmetics reform, including Personal Care Products Safety Act (S. 1113), FDA Cosmetic Safety and Modernization Act (S. 2003), Modernization of Cosmetics Regulation Act of 2018 (Senate HELP Committee Discussion Draft), Over-the-Counter Drug Safety, Innovation and Reform Act (S. 2315), and Over-the-Counter Monograph Safety, Innovation and Reform Act of 2018 (H.R. 5333)

LobbyistCovered position, as disclosed
WADE ACKERMAN —
GARY HEIMBERG —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1113 (115th), H.R. 5333 (115th), S. 2315 (115th), S. 2003 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.